| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
3 companies
Doyle William F is an Executive Chairman at NovoCure Ltd with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 30 sells.
Estimated insider holdings value: $12.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 15,000 | $16.98 | $254,700.00 | +24.5% | -11.3% | -24.4% | |
| Mar 8, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 15,000 | $16.30 | $244,500.00 | +32.4% | +11.1% | -32.3% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Executive Chairman | Sell | 837 | $69.66 | $58,304.58 | -0.2% | +0.7% | -57.1% | |
| Mar 8, 2022 | NVCR Novocure Ltd | Executive Chairman | Sell | 2,385 | $70.10 | $167,188.50 | -0.4% | +13.2% | +6.5% | |
| Aug 2, 2021 | NVCR Novocure Ltd | Executive Chairman | Sell | 995 | $149.38 | $148,631.11 | -0.2% | -28.4% | -53.4% | |
| Apr 13, 2021 | NVCR Novocure Ltd | Executive Chairman | Sell | 95,000 | $199.55 | $18,957,451.92 | -0.7% | -2.9% | -56.0% | |
| Apr 1, 2021 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 7,928 | $134.12 | $1,063,303.36 | -1.2% | +66.3% | -34.3% | |
| Jul 31, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 896 | $76.39 | $68,443.65 | -0.1% | - | - | |
| May 11, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 31,332 | $63.73 | $1,996,725.70 | -4.6% | - | - | |
| May 8, 2020 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 62,896 | $64.11 | $4,032,390.22 | -4.5% | - | - |